A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics

被引:64
作者
Wonderling, D
Hopwood, P
Cull, A
Douglas, F
Watson, M
Burn, J
McPherson, K
机构
[1] Christie Hosp NHS Trust, Canc Res Campaign, Psychol Med Grp, Manchester M20 4BX, Lancs, England
[2] Univ London London Sch Hyg & Trop Med, Canc & Publ Hlth Unit, London WC1E 7HT, England
[3] Western Gen Hosp, Imperial Canc Res Fund, Psychol Grp, Edinburgh EH4 2XU, Midlothian, Scotland
[4] Reg Genet Serv, Dept Med Genet, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England
[5] Royal Marsden Hosp, Surrey SM2 5PT, England
[6] Inst Canc Res, Surrey SM2 5PT, England
关键词
genetic counselling; cancer genetics services; health service organization; Calman-Hine;
D O I
10.1054/bjoc.2001.1893
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The objective was to describe NHS cancer genetic counselling services and compare UK regions. The study design was a cross-sectional study over 4 weeks and attendee survey. The setting was 22 of the 24 regional cancer genetics services in the UK NHS. Participants were individuals aged over 18 attending clinics at these services. Outcome measures were staff levels. referral rates. consultation rates, follow-up plans, waiting time. There were only 11 dedicated cancer geneticists across the 22 centres. Referrals were mainly concerned with breast (63%) bowel (18%) and ovarian (12%) cancers. Only 7% of referrals were for men and 3% were for individuals from ethnic minorities. Referral rates varied from 76 to 410 per million per annum across the regions. Median waiting time for an initial appointment was 19 weeks, ranging across regions from 4 to 53 weeks. Individuals at population-level genetic risk accounted for 27% of consultations (range 0%, 58%). Shortfalls in cancer genetics staff and in the provision of genetic testing and cancer surveillance have resulted in large regional variations in access to care. Initiatives to disseminate referral and management guidelines to cancer units and primary care should be adequately resourced so that clinical genetics teams can focus on the genetic testing and management of high-risk families. (C) 2001 Cancer Research Campaign hftp//www.bjcancer.com.
引用
收藏
页码:166 / 170
页数:5
相关论文
共 19 条
[1]  
[Anonymous], POL FRAM COMM CANC S
[2]   Randomized trial of a specialist genetic assessment service for familial breast cancer [J].
Brain, K ;
Gray, J ;
Norman, P ;
France, E ;
Anglim, C ;
Barton, G ;
Parsons, E ;
Clarke, A ;
Sweetland, H ;
Tischkowitz, M ;
Myring, J ;
Stansfield, K ;
Webster, D ;
Gower-Thomas, K ;
Daoud, R ;
Gateley, C ;
Monypenny, I ;
Singhal, H ;
Branston, L ;
Sampson, J ;
Roberts, E ;
Newcombe, R ;
Cohen, D ;
Rogers, C ;
Mansel, R ;
Harper, P .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1345-1351
[3]  
DEBOCK GH, 2001, BRIT MED J, V7277, P26
[4]  
EELES RA, 1996, GENETIC PREDISPOSION
[5]   Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases [J].
Emery, J ;
Walton, R ;
Murphy, M ;
Austoker, J ;
Yudkin, P ;
Chapman, C ;
Coulson, A ;
Glasspool, D ;
Fox, J .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7252) :28-32
[6]   Computer support for recording and interpreting family histories of breast and ovarian cancer in primary care (RAGs): qualitative evaluation with simulated patients [J].
Emery, J ;
Walton, R ;
Coulson, A ;
Glasspool, D ;
Ziebland, S ;
Fox, J .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 319 (7201) :32-36
[7]   Cancer genetics services in Europe [J].
Hodgson, S ;
Milner, B ;
Brown, I ;
Bevilacqua, G ;
Chang-Claude, J ;
Eccles, D ;
Evans, G ;
Gregory, H ;
Moller, P ;
Morrison, P ;
Steel, M ;
Stoppa-Lyonnet, D ;
Vasen, H ;
Haites, N .
DISEASE MARKERS, 1999, 15 (1-3) :3-13
[8]   Evaluation of questionnaire on cancer family history in identifying patients at increased genetic risk in general practice [J].
Leggatt, V ;
Mackay, J ;
Yates, JRW .
BRITISH MEDICAL JOURNAL, 1999, 319 (7212) :757-758
[9]   Cancer genetics services in Northern Ireland [J].
Morrison, PJ ;
Nevin, NC .
DISEASE MARKERS, 1999, 15 (1-3) :37-40
[10]  
Moynihan C, 1998, BRIT MED J, V317, P1072